| 2011 | 2010 | 2009 | 2008 | 2007

5 November 2010

Bioshares - Patrys sets a new pace for natural human antibody drug development

19 October 2010

Biotechnology News – Patrys trial progresses

3 August 2010

Biotechnology News - Patrys to bond with humans

Biotechnology News - Advance Opportunities investing $15M in Patrys

29 July 2010

Biotechnology News - PAT captures PAM

21 June 2010

Biotechnology News - Bio Briefs: Patrys, Calzada, Myriad and more

2 June 2010

The Australian Investor - Revolutionary biopharmaceutical company Patrys Limited (ASX: PAB) has reached important clinical and partnering milestones recently, with the scheduling of its first human clinical trial for PAT-SM6 as well as receiving its first payment under a collaboration agreement with CSL Limited.

28 May 2010

Bioshares – Patrys, watch this stock

25 May 2010

Biotechnology News - Patrys initiates melanoma trial

24 May 2010

Biotech Daily - Patrys Readies For Phase I PAT-SM6 Melanoma Trial

04 February 2010

Elsevier Business Intelligence - CSL Licenses Antibodies From Aussie Newcomer Patrys

29 January 2010

Bioshares - Patrys Secures the Attention of CSL

28 January 2010

Biotechnology News - Patrys cuts antibody licensing deal with CSL